| scholarly article | Q13442814 |
| P356 | DOI | 10.7326/0003-4819-55-2-179 |
| P698 | PubMed publication ID | 13787543 |
| P2093 | author name string | A B GUTMAN | |
| T F YU | |||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 179-192 | |
| P577 | publication date | 1961-08-01 | |
| P1433 | published in | Annals of Internal Medicine | Q564416 |
| P1476 | title | Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects | |
| P478 | volume | 55 |
| Q38326378 | A middle-aged man with pain and swelling of the hands |
| Q40569790 | Acquired Causes of Hyperuricaemia |
| Q38123116 | Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. |
| Q40300190 | Antirheumatic drugs: clinical pharmacology and therapeutic use. |
| Q35210279 | Arthritis and related diseases of the foot and ankle: rehabilitation and biomechanical considerations |
| Q72838187 | Bone marrow depression associated with acute colchicine toxicity in the presence of hepatic dysfunction |
| Q35012174 | Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study |
| Q67348657 | Clinical experiences |
| Q67445849 | Colchicine and Testicular Function in Man |
| Q36948153 | Colchicine intoxication: Clinical pharmacology, risk factors, features, and management |
| Q36190517 | Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation |
| Q36959839 | Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation. |
| Q24546235 | Diagnosis and management of gout |
| Q35522716 | Diagnosis and management of gout: a rational approach |
| Q40710710 | Effect of long-term colchicine therapy on jejunal mucosa |
| Q35127836 | Epidemiology and management of gout in Taiwan: a nationwide population study |
| Q40843166 | Gastrointestinal effects of long-term colchicine therapy in patients with recurrent polyserositis (familial Mediterranean fever) |
| Q83839631 | Gout |
| Q84110584 | Gout |
| Q94370983 | Gout |
| Q36515484 | Latest evidence on gout management: what the clinician needs to know |
| Q67692370 | Long-term colchicine prophylaxis in familial Mediterranean fever |
| Q33626316 | MALIGNANT GOUT WITH TOPHACEOUS SMALL INTESTINE AND MEGALOBLASTIC ANAEMIA. |
| Q35917060 | Management of acute and chronic gouty arthritis: present state-of-the-art |
| Q36711176 | Management of gout in older adults: barriers to optimal control |
| Q42203948 | Matching the Drug to the Patient: The rational use of antiarthritic drugs. |
| Q34305913 | Prevention and Management of Gout |
| Q69357321 | Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients |
| Q35218046 | Reproductive system in familial Mediterranean fever: an overview |
| Q35352449 | Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study |
| Q33924627 | Risk factors for gout and prevention: a systematic review of the literature |
| Q81811088 | Successful treatment of chronic tophaceous gout with infliximab (Remicade) |
| Q70470770 | The effect of intraperitoneal colchicine on the formation of peritoneal adhesions in the rat |
| Q72417674 | The efficacy of colchicine prophylaxis in articular gout—A reappraisal after 20 years |
| Q38219867 | The impact of familial Mediterranean fever on reproductive system |
| Q34776806 | The management of hyperuricemia and gout in patients with heart failure |
| Q33597442 | Treatment approaches and adherence to urate-lowering therapy for patients with gout |
| Q66965980 | Treatment of Hyperuricemia and Gout |
| Q67537681 | Understanding gout |
| Q62495112 | Urate-lowering treatment and risk of total joint replacement in patients with gout |
Search more.